ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Several reports have described the tumor-suppressor role of miR-181a in CML cells [17, 28–32]; however, the effect of miR-181a on BCR-ABL-induced leukemogenesis has not yet been elucidated.